| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |